Automated Injection of Cancer Cells in 3D ECM Scaffolds and Zebrafish Embryos for (Personalized) Compound Screening
Jan De Sonneville, Life Science Methods B.V, speaking at High Content Analysis 2014
TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
Sandra Grau-Richards, Senior Scientist/Team Leader Roche-Glycart
Advances in Volatile Analyses for Disease Diagnosis
Norman Ratcliffe, University of the West of England, speaking at Advances in Biodetection & Biosensors 2014.
Worried about your cell-based assays? Remote monitoring with CNS offers complete peace of mind!
Michael Fejtl, Market Manager, Tecan Austria
Biotransformation: Still a Bottleneck for in Vitro Kinetic and Dynamic Approaches
Sandra Coecke, European Centre for the Validation of Alternative Methods, speaking at ADME & Predictive Toxicology Europe
How to Access Screening Libraries and HTS Outside the Pharma World
Carsten Claussen, European ScreeningPort, speaking at European Lab Automation 2012
Droplet-Based Microfluidics for High-Throughput Biological Screening
Andrew deMello, Professor, ETH Zurich, speaking at Lab on a Chip World Congress 2013.
Drug-drug combinations made simple
Roderick L. Beijersbergen, Associate Professor Division of Molecular Carcinogenesis and Head NKI Robotics and Screening Center.
Your body is 3D, why is your cell culture not?
Christian Oberdanner, PhD, Application Specialist Sales & Marketing, Tecan Austria GmbH